Dice Molecules Holdings Financials

Dice Molecules Stock Summary

Dice Molecules competes with Nuvalent, Arcellx, Vaxcyte, Viridian Therapeutics, and Ventyx Biosciences. DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was incorporated in 2013 and is headquartered in South San Francisco, California. Dice Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.

Dice Molecules Key Financial Ratios

Dice Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Dice Molecules's current stock value. Our valuation model uses many indicators to compare Dice Molecules value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dice Molecules competition to find correlations between indicators driving Dice Molecules's intrinsic value. More Info.Dice Molecules Holdings is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Dice Molecules by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

If you are still planning to invest in Dice Molecules Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dice Molecules' history and understand the potential risks before investing.